TheHealthSite

Mumbai, India Founded: 2013 • Age: 13 yrs Listed

Provides health information, yoga routines, diet tips, and pregnancy advice online.

Page last updated 19 Oct 2026

About TheHealthSite

TheHealthSite is a publicly listed company based in Mumbai (India) founded in 2013. It provides health information, yoga routines, diet tips, and pregnancy advice online. It operates on a B2C model. Its website thehealthsite.com draws about 587 thousand monthly visits. Its Indian entity Zee Media Corporation Limited reported revenue of ₹776 Cr. TheHealthSite offers products and services including Health Articles, Yoga Routines, and Diet Tips. Its focus areas include Consumer, Health Tech, Digital Health and Health Content. Its competitors include Fitpage and MyUpchar; 2 of its 2 listed competitors have raised funding.

Company details

TheHealthSite.com, run by India Dot Com Private Limited, delivers digital content on health topics including diseases, fitness, yoga, and pregnancy. It offers articles, videos, and expert opinions to educate users on wellness practices. Based in Mumbai, India, it serves a global audience with practical health guidance and lifestyle tips, focusing on areas like mental health and nutrition without promotional bias.

Headquarters Mumbai, India
Stage Public
Sectors
Healthcare
Website category Health
Email
••••••••
Website thehealthsite.com
Social X Facebook Instagram
Legal Name India Dot Com Private Limited
Date of Incorporation 27 Aug, 1999

Operational Areas

Healthcare → Digital Health & Telemedicine

Healthcare → Fitness & Wellness Platforms

Key Metrics

Market Cap
₹461 Cr
ZEEMEDIA · NSE
Share Price
₹6.86
-2.56% today
Revenue
₹759 Cr
FY 2025-26 · +22.1% YoY
EBITDA
₹101 Cr
Margin 13.3%
Net Profit
₹6.66 Cr
FY 2025-26 · +105.8% YoY
P/E (TTM)
136.0x
P/B 2.9x

Associated legal entities of TheHealthSite

TheHealthSite is associated with 2 registered companies on The Company Check; the primary company is Zee Media Corporation Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.

Legal entity	Status	Incorporated	Registered in	Revenue (FY 2026)	Employees	Directors	Company page
Zee Media Corporation Limited Listed CIN L92100MH1999PLC121506	Active	27 Aug 1999	Mumbai, Maharashtra	₹776 Cr	2,177	9	View details
Indiadotcom Digital Private Limited CIN U93000UP2020PTC137165	Active	29 Oct 2020	Noida, Uttar Pradesh	₹131 Cr	743	5	View details

Products & Services of TheHealthSite

TheHealthSite offers a comprehensive portfolio of products and services, including Health Articles, Yoga Routines, and Diet Tips.

Health Articles

Content Service

Delivers informative pieces on diseases and wellness topics

Yoga Routines

Fitness Service

Provides daily yoga asanas for stress reduction and health

Diet Tips

Nutrition Service

Offers advice on healthy eating and weight management options

Board of directors of Zee Media Corporation Limited (TheHealthSite)

Zee Media Corporation Limited is the primary company behind TheHealthSite. The boards of the 2 registered companies of TheHealthSite currently have 8 directors; the longest-serving is Raj Kumar Gupta, appointed in 2019. 44 earlier directors have ceased.

Director	Designation	Appointed	Tenure	Entity
Raj Kumar Gupta DIN 02223210	Director	30 Mar 2019	7 yrs 7 mo	Zee Media Corporation Limited, Indiadotcom Digital Private Limited
Dinesh Kumar Garg DIN 02048097	Whole-time director	20 Sep 2019	7 yrs 1 mo	Zee Media Corporation Limited
Amitabh Kumar DIN 00222260	Director	26 Mar 2020	6 yrs 7 mo	Zee Media Corporation Limited
Surender Singh DIN 08206770	Director	01 Jul 2020	6 yrs 3 mo	Zee Media Corporation Limited
Susanta Kumar Panda DIN 07917003	Director	01 Sep 2020	6 yrs 1 mo	Zee Media Corporation Limited
Umesh Kumar DIN 08931021	Director	29 Oct 2020	6 yrs	Indiadotcom Digital Private Limited
Swetha Gopalan DIN 09167355	Director	01 Aug 2021	5 yrs 2 mo	Zee Media Corporation Limited, Indiadotcom Digital Private Limited
Rahul Garg DIN 10776047	CFO	30 Aug 2024	2 yrs 2 mo	Indiadotcom Digital Private Limited

IPO & Listings of TheHealthSite

TheHealthSite is a publicly listed company on the NSE with ticker symbol ZEEMEDIA in India, operating in the Media - Print/Television/Radio sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Listed onNSE: ZEEMEDIA
Listed entityZee Media Corporation Limited
Exchange sectorMedia - Print/Television/Radio

Financials of TheHealthSite

Exchange-reported figures of Zee Media Corporation Limited, the listed company behind TheHealthSite (NSE: ZEEMEDIA).

Financial Highlights

FY 2025-26 · Consolidated

Revenue

₹759 Cr

+22.1% YoY

EBITDA

₹101 Cr

+433.0% YoY

Profit After Tax

₹6.66 Cr

+105.7% YoY

Net Worth

₹224 Cr

+1.4% YoY

Total Assets

₹346 Cr

-27.5% YoY

Total Debt

₹83.22 Cr

-52.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	759	622	638	721	867	649	632
Revenue growth	+22.1%	-2.6%	-11.4%	-16.9%	+33.6%	+2.7%	-
EBITDA	101	(30.31)	(50.42)	29.44	40.01	198	(150)
EBITDA margin	+13.3%	-4.9%	-7.9%	+4.1%	+4.6%	+30.5%	-23.8%
Profit before tax	(5.76)	(160)	(127)	(72.76)	(72.71)	107	(243)
Net profit	6.66	(116)	(95.64)	(40.17)	150	83.79	26.23
Net profit margin	+0.9%	-18.6%	-15.0%	-5.6%	+17.3%	+12.9%	+4.2%
EPS (₹)	0.03	(1.91)	(1.57)	(1.10)	(1.88)	1.61	(5.76)
Balance sheet
Total assets	346	477	588	619	736	929	554
Net worth	224	221	289	387	456	532	365
Total debt	83.22	174	246	199	244	366	118
Cash & bank	9.49	14.23	9.70	13.98	36.03	90.69	53.23
Net working capital	(165)	(124)	(129)	(19.65)	287	554	156
Cash flow
Cash from operations	98.34	63.54	76.94	146	230	123	164
Cash from investing	(3.55)	(7.31)	14.59	(97.68)	(166)	(43.55)	(26.52)
Cash from financing	(82.98)	(48.32)	(92.34)	(93.31)	(120)	(28.98)	(50.74)

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	191	158	240	179	182	156	159	131
Revenue growth (YoY)	+4.7%	+1.3%	+50.7%	+36.7%	+3.6%	-	-	-
Other income	1.66	14.18	0.98	1.24	0.75	5.92	1.33	2.42
EBITDA	16.26	(14.14)	78.18	17.10	19.78	(19.35)	6.49	(31.43)
EBITDA margin	+8.5%	-9.0%	+32.5%	+9.6%	+10.8%	-12.4%	+4.1%	-24.0%
Depreciation	26.08	24.83	25.61	26.76	27.17	28.79	29.88	30.13
Interest	5.09	5.12	4.67	4.87	4.80	7.31	7.82	7.39
Profit before tax	(13.25)	(29.91)	48.88	(13.29)	(11.44)	(49.53)	(29.88)	(66.53)
Tax	(1.13)	(3.38)	(3.89)	2.24	(2.63)	(12.77)	(7.46)	(16.67)
Net profit	(12.12)	(26.53)	52.77	(15.53)	(8.81)	(36.76)	(22.42)	(49.86)
EPS (₹)	(0.19)	(0.42)	0.84	(0.25)	(0.14)	(0.59)	(0.36)	(0.79)

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	572	455	458	517	655	573	559
Revenue growth	+25.6%	-0.6%	-11.5%	-21.1%	+14.3%	+2.5%	-
EBITDA	98.16	(29.41)	(59.56)	24.26	(12.91)	160	(188)
EBITDA margin	+17.2%	-6.5%	-13.0%	+4.7%	-2.0%	+28.0%	-33.7%
Profit before tax	13.37	(136)	(113)	(44.68)	109	84.89	(267)
Net profit	16.93	(109)	(83.30)	(7.73)	58.81	67.00	16.05
Net profit margin	+3.0%	-23.9%	-18.2%	-1.5%	+9.0%	+11.7%	+2.9%
EPS (₹)	0.27	(1.60)	(1.37)	(0.72)	1.34	1.26	(6.13)
Balance sheet
Total assets	556	672	748	786	877	876	519
Net worth	445	427	477	563	608	483	333
Total debt	82.39	172	243	197	238	363	118
Cash & bank	0.85	0.62	0.45	9.95	12.12	63.93	19.85
Net working capital	(164)	(145)	(139)	(24.29)	320	476	98.79
Cash flow
Cash from operations	75.20	51.72	61.75	139	115	122	125
Cash from investing	22.97	(1.57)	22.95	(73.63)	(50.40)	(37.08)	(10.66)
Cash from financing	(81.07)	(46.65)	(90.70)	(90.19)	(118)	(27.92)	(49.81)

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	132	113	200	117	142	117	117	94.29
Revenue growth (YoY)	-6.5%	-4.2%	+71.1%	+24.5%	+12.2%	-	-	-
Other income	2.06	15.53	0.94	0.63	0.60	5.38	0.51	2.25
Total expenses	117	117	116	117	124	125	113	123
EBITDA	15.03	(4.34)	84.24	0.84	17.42	(7.14)	3.74	(28.91)
EBITDA margin	+11.4%	-3.9%	+42.1%	+0.7%	+12.3%	-6.1%	+3.2%	-30.7%
Depreciation	20.91	20.35	20.29	21.40	21.76	22.79	23.57	23.81
Interest	4.95	4.78	4.56	4.69	4.66	7.59	7.34	7.29
Profit before tax	(8.77)	(13.94)	60.33	(24.62)	(8.40)	(32.14)	(26.66)	(57.76)
Tax	0.05	0.38	(1.16)	(1.00)	(1.78)	(9.46)	(6.71)	(14.52)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 30 Oct 2026

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	191	158	240	179	182	156	159	131
Revenue growth (YoY)	+4.7%	+1.3%	+50.7%	+36.7%	+3.6%	-	-	-
Other income	1.66	14.18	0.98	1.24	0.75	5.92	1.33	2.42
EBITDA	16.26	(14.14)	78.18	17.10	19.78	(19.35)	6.49	(31.43)
EBITDA margin	+8.5%	-9.0%	+32.5%	+9.6%	+10.8%	-12.4%	+4.1%	-24.0%
Depreciation	26.08	24.83	25.61	26.76	27.17	28.79	29.88	30.13
Interest	5.09	5.12	4.67	4.87	4.80	7.31	7.82	7.39
Profit before tax	(13.25)	(29.91)	48.88	(13.29)	(11.44)	(49.53)	(29.88)	(66.53)
Tax	(1.13)	(3.38)	(3.89)	2.24	(2.63)	(12.77)	(7.46)	(16.67)
Net profit	(12.12)	(26.53)	52.77	(15.53)	(8.81)	(36.76)	(22.42)	(49.86)
EPS (₹)	(0.19)	(0.42)	0.84	(0.25)	(0.14)	(0.59)	(0.36)	(0.79)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	759	622	638	721	867	649	632
Revenue growth	+22.1%	-2.6%	-11.4%	-16.9%	+33.6%	+2.7%	-
Other income	17.15	19.87	32.76	19.12	9.95	14.28	19.06
Total expenses	658	652	689	691	827	451	782
Employee cost	0.00	221	248	262	220	167	159
EBITDA	101	(30.31)	(50.42)	29.44	40.01	198	(150)
EBITDA margin	+13.3%	-4.9%	-7.9%	+4.1%	+4.6%	+30.5%	-23.8%
Depreciation	104	119	84.94	91.65	84.86	80.77	87.97
Interest	19.46	30.40	24.14	29.67	37.81	24.32	24.01
Profit before tax	(5.76)	(160)	(127)	(72.76)	(72.71)	107	(243)
Tax	(7.66)	(40.48)	(28.31)	(3.95)	45.01	31.28	27.77
Net profit	6.66	(116)	(95.64)	(40.17)	150	83.79	26.23
Net profit margin	+0.9%	-18.6%	-15.0%	-5.6%	+17.3%	+12.9%	+4.2%
EPS (₹)	0.03	(1.91)	(1.57)	(1.10)	(1.88)	1.61	(5.76)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	62.54	62.54	62.54	62.54	62.54	47.08	47.08
Reserves & surplus	70.05	66.99	186	284	353	469	318
Shareholders' funds (net worth)	224	221	289	387	456	532	365
Minority interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Secured loans	10.58	78.40	135	196	214	317	118
Unsecured loans	72.64	95.32	111	3.42	30.34	49.22	0.00
Total debt	83.22	174	246	199	244	366	118
Total liabilities	346	477	588	619	736	929	554
Assets
Gross block	913	936	957	674	662	562	537
Net block	323	428	555	340	329	262	294
Capital work in progress	0.32	0.88	0.39	2.25	0.56	0.00	0.22
Investments	41.63	42.79	42.41	58.29	79.94	70.55	70.32
Inventories	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sundry debtors	314	199	206	152	238	238	200
Cash & bank balances	9.49	14.23	9.70	13.98	36.03	90.69	53.23
Loans & advances	38.62	65.70	36.26	68.27	247	401	75.01
Total current assets	363	279	252	234	521	730	328
Total current liabilities	527	403	380	254	235	176	173
Net working capital	(165)	(124)	(129)	(19.65)	287	554	156
Total assets	346	477	588	619	736	929	554

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	(12.08)	(20.00)	(19.20)	25.55	81.96	31.32	(55.29)
Net cash from operating activities	98.34	63.54	76.94	146	230	123	164
Net cash from investing activities	(3.55)	(7.31)	14.59	(97.68)	(166)	(43.55)	(26.52)
Net cash from financing activities	(82.98)	(48.32)	(92.34)	(93.31)	(120)	(28.98)	(50.74)
Net change in cash	11.80	7.91	(0.80)	(44.75)	(56.41)	50.64	86.60
Closing cash	9.49	14.23	9.70	13.98	36.03	90.69	53.23

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	+22.1%	-2.6%	-11.4%	-16.9%	+33.6%	+2.7%	-
EBITDA growth	+433.0%	+39.9%	-271.3%	-26.4%	-79.8%	+231.5%	-
PBT growth	+96.4%	-26.2%	-74.2%	-0.1%	-	+9998.0%	-
Net income growth	+105.8%	-21.2%	-138.1%	-126.8%	+79.1%	+219.4%	-
Revenue CAGR (3Y)	+1.8%	-10.5%	-0.6%	+4.5%	+8.1%	+4.2%	+12.0%
EBITDA CAGR (3Y)	+50.8%	-	-	-	-7.3%	+22.7%	-
Profitability & leverage
Net income margin	+0.3%	-19.2%	-15.4%	-9.6%	-13.6%	+11.7%	-42.9%
Return on capital employed	-	0.0%	0.0%	0.0%	0.0%	+19.4%	0.0%
Return on net worth	-	0.0%	0.0%	0.0%	0.0%	+18.7%	0.0%
Debt / equity	-	0.82	0.66	0.53	0.62	0.54	0.31
Long-term debt / equity	-	0.33	0.32	0.34	0.45	0.40	0.19
Interest cover	-564.06	-20.35	-17.83	-47.69	-84.30	20.77	-10.07
Efficiency & per share
Fixed asset turnover	-	0.66	0.78	1.08	1.42	1.18	1.28
Inventory turnover	-	0.00	0.00	0.00	0.00	0.00	388.77
Debtors turnover	-	3.07	3.57	3.69	3.64	2.96	3.10
EPS (₹)	0.03	(1.91)	(1.57)	(1.10)	(1.88)	1.61	(5.76)
Dividend per share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	0.00	2.07	3.97	5.53	6.64	10.97	7.75

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	132	113	200	117	142	117	117	94.29
Revenue growth (YoY)	-6.5%	-4.2%	+71.1%	+24.5%	+12.2%	-	-	-
Other income	2.06	15.53	0.94	0.63	0.60	5.38	0.51	2.25
Total expenses	117	117	116	117	124	125	113	123
EBITDA	15.03	(4.34)	84.24	0.84	17.42	(7.14)	3.74	(28.91)
EBITDA margin	+11.4%	-3.9%	+42.1%	+0.7%	+12.3%	-6.1%	+3.2%	-30.7%
Depreciation	20.91	20.35	20.29	21.40	21.76	22.79	23.57	23.81
Interest	4.95	4.78	4.56	4.69	4.66	7.59	7.34	7.29
Profit before tax	(8.77)	(13.94)	60.33	(24.62)	(8.40)	(32.14)	(26.66)	(57.76)
Tax	0.05	0.38	(1.16)	(1.00)	(1.78)	(9.46)	(6.71)	(14.52)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	572	455	458	517	655	573	559
Revenue growth	+25.6%	-0.6%	-11.5%	-21.1%	+14.3%	+2.5%	-
Other income	17.70	17.44	26.27	20.64	227	13.46	16.78
Total expenses	473	484	517	493	668	413	748
Employee cost	0.00	161	177	179	175	157	149
EBITDA	98.16	(29.41)	(59.56)	24.26	(12.91)	160	(188)
EBITDA margin	+17.2%	-6.5%	-13.0%	+4.7%	-2.0%	+28.0%	-33.7%
Depreciation	83.80	94.12	56.82	62.91	67.58	65.04	71.83
Interest	18.69	29.81	22.85	26.67	36.57	24.03	23.79
Profit before tax	13.37	(136)	(113)	(44.68)	109	84.89	(267)
Tax	(3.56)	(35.55)	(26.96)	0.30	25.92	25.75	21.47
Net profit	16.93	(109)	(83.30)	(7.73)	58.81	67.00	16.05
Net profit margin	+3.0%	-23.9%	-18.2%	-1.5%	+9.0%	+11.7%	+2.9%
EPS (₹)	0.27	(1.60)	(1.37)	(0.72)	1.34	1.26	(6.13)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	62.54	62.54	62.54	62.54	62.54	47.08	47.08
Reserves & surplus	291	273	373	459	504	421	286
Shareholders' funds (net worth)	445	427	477	563	608	483	333
Secured loans	10.46	28.26	135	196	214	317	118
Unsecured loans	71.93	143	108	1.60	24.66	46.58	0.00
Total debt	82.39	172	243	197	238	363	118
Total liabilities	556	672	748	786	877	876	519
Assets
Gross block	664	681	692	404	455	477	459
Net block	223	305	397	155	178	221	246
Capital work in progress	0.32	0.88	0.00	1.69	0.56	0.00	0.22
Investments	378	403	407	433	342	133	133
Inventories	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sundry debtors	287	172	169	112	221	216	183
Cash & bank balances	0.85	0.62	0.45	9.95	12.12	63.93	19.85
Loans & advances	30.39	37.69	21.52	31.68	250	360	58.83
Total current assets	319	210	191	154	483	640	262
Total current liabilities	483	355	330	178	163	164	163
Net working capital	(164)	(145)	(139)	(24.29)	320	476	98.79
Total assets	556	672	748	786	877	876	519

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	(25.35)	(28.85)	(22.85)	1.70	55.20	(2.07)	(66.92)
Net cash from operating activities	75.20	51.72	61.75	139	115	122	125
Net cash from investing activities	22.97	(1.57)	22.95	(73.63)	(50.40)	(37.08)	(10.66)
Net cash from financing activities	(81.07)	(46.65)	(90.70)	(90.19)	(118)	(27.92)	(49.81)
Net change in cash	17.10	3.50	(6.00)	(24.54)	(53.50)	57.27	64.85
Closing cash	(8.25)	0.62	0.45	9.95	12.12	63.93	19.85

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	+25.6%	-0.6%	-11.5%	-21.1%	+14.3%	+2.5%	-
EBITDA growth	+433.8%	+50.6%	-345.5%	+287.9%	-108.0%	+185.3%	-
PBT growth	+9998.0%	-20.3%	-152.8%	-	+28.9%	+9998.0%	-825.3%
Net income growth	+115.6%	-30.5%	-977.6%	-113.1%	-12.2%	+317.5%	-
Revenue CAGR (3Y)	+3.4%	-11.4%	-7.2%	-2.6%	+2.6%	+4.0%	+12.0%
EBITDA CAGR (3Y)	+59.4%	+31.6%	-	-	-	+16.1%	-
Profitability & leverage
Net income margin	+3.0%	-22.1%	-18.8%	-8.7%	+12.8%	+10.3%	-51.6%
Return on capital employed	-	0.0%	0.0%	+2.6%	+12.5%	+16.9%	0.0%
Return on net worth	-	0.0%	0.0%	-1.3%	+10.4%	+15.7%	0.0%
Debt / equity	-	0.46	0.42	0.37	0.55	0.59	0.33
Long-term debt / equity	-	0.19	0.21	0.24	0.40	0.44	0.19
Interest cover	130.15	-24.13	-19.63	-69.00	-45.43	25.17	-9.15
Efficiency & per share
Fixed asset turnover	-	0.66	0.84	1.20	1.41	1.22	1.33
Inventory turnover	-	0.00	0.00	0.00	0.00	0.00	344.22
Debtors turnover	-	2.67	3.26	3.10	2.99	2.87	3.04
EPS (₹)	0.27	(1.60)	(1.37)	(0.72)	1.34	1.26	(6.13)
Dividend per share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	0.00	5.37	6.96	8.34	9.06	9.93	7.07

Competitors of TheHealthSite

TheHealthSite has 2 listed competitors in our database, 2 of them funded. They include Fitpage and MyUpchar.

Company Name	Domain	Founded	HQ Location	Total funding	Employees	Description
Fitpage	fitpage.in	2020	Mumbai, India	$4.86M	40	Fitness and wellness content is delivered via an online platform.
MyUpchar	myupchar.com	2016	Delhi, India	$5.35M	8	Health information portal is provided online in 13 Indian languages.

Premium access

Detailed competitors of TheHealthSite

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

Full competitor set
Operating metrics
Benchmarks
Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of TheHealthSite

The website of TheHealthSite (thehealthsite.com) receives about 586.6K visits a month and ranks #99,272 among all websites worldwide, #2,867 in Health.

Monthly visits
586.6K
▼ 5.5% vs previous month
Unique visitors
414.7K
per month
Global rank
#99,272
among all websites
Category rank
#2,867
Health · Health

Visitor engagement

Bounce rate54%
Pages per visit1.6
Average visit37 sec
Devices
Desktop 15% · Mobile 85%

Similar websites

Websites whose visitors overlap most with TheHealthSite. Affinity shows how closely the audiences match.

Website	Domain	Audience affinity	Monthly visits	Global rank	Profile
Medindia	medindia.net	88%	828.7K	#78,367	View details
Hugg	gethugg.com	80%	144.1K	#286,060	View details
Holland Hospital	hollandhospital.org	76%	63.7K	#573,127	View details
Indus Health Plus	indushealthplus.com	74%	30.1K	#974,119	View details
Happiest Health	happiesthealth.com	73%	291.7K	#262,964	View details
••••••••••	••••••.com	••%	•.•M	#•••••	–
••••••••••	••••••.com	••%	•.•M	#•••••	–
••••••••••	••••••.com	••%	•.•M	#•••••	–

Premium access

All 23 similar websites and full traffic analytics for TheHealthSite

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

23 similar websites
Audience overlap
Engagement analytics
Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Digital Health & Telemedicine

3 companies that operate in the same segment as TheHealthSite (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Tata 1mg	Provider of an online pharmacy with doctor listing and teleconsultation services	2015	Delhi, Delhi, India	USD 199.65 M	USD 328.97 M	5,212
MediBuddy	Online platform offering multiple healthcare services	2013	Bengaluru, Karnataka, India	USD 199.22 M	USD 62.4 M	52
SastaSundar	An online marketplace for healthcare products is operated.	2011	Kolkata, West Bengal, India	USD 38.26 M

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.

Included in your Premium account

✓
Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
✓
Full access to every database India & global coverage, advanced filters and rich profile details
✓
Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about TheHealthSite

When was TheHealthSite founded?

TheHealthSite was founded in 2013.

Where is TheHealthSite located?

TheHealthSite is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

What is the annual revenue of TheHealthSite?

The primary company behind TheHealthSite, Zee Media Corporation Limited, reported revenue of ₹776 Cr for FY 2026, up 22% year on year.

What does TheHealthSite do?

Who are the top competitors of TheHealthSite?

TheHealthSite's top competitors include Fitpage and MyUpchar.

What products or services does TheHealthSite offer?

TheHealthSite offers Health Articles, Yoga Routines, and Diet Tips.

Is TheHealthSite publicly traded?

Yes, TheHealthSite is publicly traded on NSE under the ticker symbol ZEEMEDIA.

Which legal entities are associated with TheHealthSite?

TheHealthSite is associated with 2 legal entities: Zee Media Corporation Limited, Indiadotcom Digital Private Limited.

Who are the directors of TheHealthSite?

The legal entities of TheHealthSite currently have 11 directors, including Raj Kumar Gupta, Amitabh Kumar, Susanta Kumar Panda and others.

How much web traffic does TheHealthSite get?

The website of TheHealthSite receives about 587 thousand visits a month and ranks #99,272 among all websites worldwide.